MARK GILGER to Proton Pump Inhibitors
This is a "connection" page, showing publications MARK GILGER has written about Proton Pump Inhibitors.
Connection Strength
1.644
-
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S16-23.
Score: 0.352
-
Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S31-6.
Score: 0.352
-
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S16-23.
Score: 0.352
-
Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S31-6.
Score: 0.352
-
Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S24-30.
Score: 0.088
-
Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S24-30.
Score: 0.088
-
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. BMC Pediatr. 2010 Jun 11; 10:41.
Score: 0.062